These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
294 related articles for article (PubMed ID: 15122581)
21. Prostate cancer cells regulate growth and differentiation of bone marrow endothelial cells through TGFbeta and its receptor, TGFbetaRII. Barrett JM; Rovedo MA; Tajuddin AM; Jilling T; Macoska JA; MacDonald J; Mangold KA; Kaul KL Prostate; 2006 May; 66(6):632-50. PubMed ID: 16388503 [TBL] [Abstract][Full Text] [Related]
22. Vascular endothelial growth factor contributes to prostate cancer-mediated osteoblastic activity. Kitagawa Y; Dai J; Zhang J; Keller JM; Nor J; Yao Z; Keller ET Cancer Res; 2005 Dec; 65(23):10921-9. PubMed ID: 16322239 [TBL] [Abstract][Full Text] [Related]
23. Derivation of androgen-independent human LNCaP prostatic cancer cell sublines: role of bone stromal cells. Wu HC; Hsieh JT; Gleave ME; Brown NM; Pathak S; Chung LW Int J Cancer; 1994 May; 57(3):406-12. PubMed ID: 8169003 [TBL] [Abstract][Full Text] [Related]
24. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer. Feeley BT; Gamradt SC; Hsu WK; Liu N; Krenek L; Robbins P; Huard J; Lieberman JR J Bone Miner Res; 2005 Dec; 20(12):2189-99. PubMed ID: 16294272 [TBL] [Abstract][Full Text] [Related]
25. Notch signaling and ERK activation are important for the osteomimetic properties of prostate cancer bone metastatic cell lines. Zayzafoon M; Abdulkadir SA; McDonald JM J Biol Chem; 2004 Jan; 279(5):3662-70. PubMed ID: 14602722 [TBL] [Abstract][Full Text] [Related]
26. An EP4 antagonist ONO-AE3-208 suppresses cell invasion, migration, and metastasis of prostate cancer. Xu S; Zhang Z; Ogawa O; Yoshikawa T; Sakamoto H; Shibasaki N; Goto T; Wang L; Terada N Cell Biochem Biophys; 2014 Sep; 70(1):521-7. PubMed ID: 24744183 [TBL] [Abstract][Full Text] [Related]
27. Phage display selection of peptides that affect prostate carcinoma cells attachment and invasion. Romanov VI; Durand DB; Petrenko VA Prostate; 2001 Jun; 47(4):239-51. PubMed ID: 11398171 [TBL] [Abstract][Full Text] [Related]
28. Prostate cancer cell adhesion to bone marrow endothelium: the role of prostate-specific antigen. Romanov VI; Whyard T; Adler HL; Waltzer WC; Zucker S Cancer Res; 2004 Mar; 64(6):2083-9. PubMed ID: 15026347 [TBL] [Abstract][Full Text] [Related]
29. Loss of TGF-β responsiveness in prostate stromal cells alters chemokine levels and facilitates the development of mixed osteoblastic/osteolytic bone lesions. Li X; Sterling JA; Fan KH; Vessella RL; Shyr Y; Hayward SW; Matrisian LM; Bhowmick NA Mol Cancer Res; 2012 Apr; 10(4):494-503. PubMed ID: 22290877 [TBL] [Abstract][Full Text] [Related]
30. IL-17 and insulin/IGF1 enhance adhesion of prostate cancer cells to vascular endothelial cells through CD44-VCAM-1 interaction. Chen C; Zhang Q; Liu S; Parajuli KR; Qu Y; Mei J; Chen Z; Zhang H; Khismatullin DB; You Z Prostate; 2015 Jun; 75(8):883-95. PubMed ID: 25683512 [TBL] [Abstract][Full Text] [Related]
31. In vitro the behaviors of metastasis with suppression of VEGF in human bone metastatic LNCaP-derivative C4-2B prostate cancer cell line. Yang L; You S; Kumar V; Zhang C; Cao Y J Exp Clin Cancer Res; 2012 May; 31(1):40. PubMed ID: 22549243 [TBL] [Abstract][Full Text] [Related]
32. Rat prostate adenocarcinoma cells disseminate to bone and adhere preferentially to bone marrow-derived endothelial cells. Haq M; Goltzman D; Tremblay G; Brodt P Cancer Res; 1992 Sep; 52(17):4613-9. PubMed ID: 1511429 [TBL] [Abstract][Full Text] [Related]
33. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment. Chung LW; Baseman A; Assikis V; Zhau HE J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017 [TBL] [Abstract][Full Text] [Related]
34. Intraosseous growth of human prostate cancer in implanted adult human bone: relationship of prostate cancer cells to osteoclasts in osteoblastic metastatic lesions. Yonou H; Ochiai A; Goya M; Kanomata N; Hokama S; Morozumi M; Sugaya K; Hatano T; Ogawa Y Prostate; 2004 Mar; 58(4):406-13. PubMed ID: 14968441 [TBL] [Abstract][Full Text] [Related]
35. Vascular endothelial growth factor contributes to the prostate cancer-induced osteoblast differentiation mediated by bone morphogenetic protein. Dai J; Kitagawa Y; Zhang J; Yao Z; Mizokami A; Cheng S; Nör J; McCauley LK; Taichman RS; Keller ET Cancer Res; 2004 Feb; 64(3):994-9. PubMed ID: 14871830 [TBL] [Abstract][Full Text] [Related]
36. The bisphosphonate YM529 inhibits osteolytic and osteoblastic changes and CXCR-4-induced invasion in prostate cancer. Miwa S; Mizokami A; Keller ET; Taichman R; Zhang J; Namiki M Cancer Res; 2005 Oct; 65(19):8818-25. PubMed ID: 16204052 [TBL] [Abstract][Full Text] [Related]
37. Probing the interaction forces of prostate cancer cells with collagen I and bone marrow derived stem cells on the single cell level. Sariisik E; Docheva D; Padula D; Popov C; Opfer J; Schieker M; Clausen-Schaumann H; Benoit M PLoS One; 2013; 8(3):e57706. PubMed ID: 23472100 [TBL] [Abstract][Full Text] [Related]
38. Hypoxia increases VEGF-A production by prostate cancer and bone marrow stromal cells and initiates paracrine activation of bone marrow endothelial cells. Muir C; Chung LW; Carson DD; Farach-Carson MC Clin Exp Metastasis; 2006; 23(1):75-86. PubMed ID: 16826426 [TBL] [Abstract][Full Text] [Related]
39. Identification of metastasis-associated genes in prostate cancer by genetic profiling of human prostate cancer cell lines. Trojan L; Schaaf A; Steidler A; Haak M; Thalmann G; Knoll T; Gretz N; Alken P; Michel MS Anticancer Res; 2005; 25(1A):183-91. PubMed ID: 15816537 [TBL] [Abstract][Full Text] [Related]
40. [Expression of "epithelial-mesenchymal transition" associated proteins in prostate cancer cell lines with different metastatic potentials and its significance]. Luo Y; He DL; Ning L Zhonghua Nan Ke Xue; 2006 Aug; 12(8):696-700. PubMed ID: 16970156 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]